HER2-directed T-cell receptor-mimicking antibody: a "Me Too" or an example of novel antitumor aggressive mimicry?

J Natl Cancer Inst. 2013 Feb 6;105(3):161-3. doi: 10.1093/jnci/djs636. Epub 2013 Jan 8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Female
  • HLA-A2 Antigen / drug effects*
  • Humans
  • Intracellular Signaling Peptides and Proteins / drug effects*
  • Neoplasms / drug therapy*
  • Oncogene Proteins, Fusion / antagonists & inhibitors*
  • Receptor, ErbB-2 / antagonists & inhibitors*
  • Receptors, Antigen, T-Cell / agonists*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • HLA-A2 Antigen
  • Intracellular Signaling Peptides and Proteins
  • Oncogene Proteins, Fusion
  • Receptors, Antigen, T-Cell
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab